Narcotic Analgesics

ABSTRAL (fentanyl) transmucosal immediate-release tablets by ProStrakan

Abstral transmucosal tablets approved for breakthrough cancer pain

Abstral (fentanyl transmucosal immediate-release tablets, from ProStrakan) has been approved by the FDA for the management of breakthrough pain in adult patients with cancer, ≥18 years old, who already use opioid pain medication around the clock and who need and are able to safely use high doses of an additional opioid medicine.

FDA Video: Dosing Errors with Certain Oral Syringes

The Institute for Safe Medication Practices (ISMP) recently pointed out that measuring doses with certain oral syringes can be confusing for healthcare practitioners and patients, and that this can lead to overdoses.